Though some cancer patients lack sufficient enzymes to metabolize capecitabine or 5-FU, many patients are not warned about the risks associated with these treatments.

There’s a worrying trend in the cancer world with young adults getting cancer at higher rates, and scientists don’t know why.

With two-thirds of patients diagnosed at an advanced stage, an oncologist shares how greater awareness of the disease and new ...

There is no cure; the best we can do is supportive care and try to limit some of the worst effects. So, please, if a child ...

A 34-year-old man was admitted to the hospital because of left ear pain with hearing loss and facial droop on the left side.

The multiple regulatory designations were granted following strong positive results from a global randomized Phase 1b/2 study in first-line HCC demonstrating superior outcomes for amezalpat ...

The latest update atopic dermatitis guidelines include the new approval of lebrikizumab and the expanded use of baricitinib ...

Vidac Pharma, a clinical-stage biopharmaceutical company developing innovative cancer therapies, is pleased to announce the ...

Dr. Nicholas James presented a study assessing a multimodal artificial intelligence (MMAI) model to identify benefit from 2nd-generation androgen receptor pathway inhibitors (ARPI) in high-risk ...

The Supreme Court is entering its busiest period for deciding important cases. Opinions could drop soon on birthright ...